Skip to search formSkip to main content

SU 10944

Known as: SU-10944, SU10944 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Vascular patterning and permeability in prostate cancer models with differing osteogenic properties.
Bone metastasis is a major cause of morbidity and mortality in prostate cancer. However, the lack of clinically relevant models… Expand
Is this relevant?
2009
2009
Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy
PURPOSE Annexin A2 has been shown to play a role in many neovascularization diseases. We investigated the effect of vascular… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248.
Recent achievements in the development of multitargeted molecular inhibitors necessitate a better understanding of the… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2003
2003
A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability.
Vascular endothelial growth factor (VEGF) is a key driver of the neovascularization and vascular permeability that leads to the… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 1
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE